Remember meForgot password?
    Log in with Twitter

article imageMissionary with Ebola repatriated to Spain has died

By Anne Sewell     Aug 12, 2014 in Health
Madrid - Miguel Pajares, 75, was recently brought home to Spain from Liberia, suffering from the deadly Ebola virus. Despite being treated with the experimental drug ZMapp, he has reportedly passed away from the disease on Tuesday morning.
The Spanish priest was treated at the Carlos III hospital in Madrid with the new experimental drug ZMapp, but regrettably failed to respond to the treatment and died at 9:28 a.m. Tuesday morning, according to Madrid's Health Department.
The health ministry advised late on Saturday that the experimental drug had arrived at the hospital where the 75-year-old missionary was being treated in isolation. The serum has recently been used on two Ebola sufferers, repatriated to the United States.
Pajares was infected with the virus while working in a hospital in the Liberian capital of Monrovia. He was previously kept in isolation at the Hospitaller Order of Saint John of God hospital in Monrovia.
He reportedly came down with the virus after visiting the director of the hospital. Pajares belongs to the San Juan de Dios religious order and had been caring for and feeding the director of the hospital, Patrick Nshamdze, from Cameroon, who died on Saturday from the virus.
Two of Pajares' colleagues back in Liberia, George Combey and missionary Chantal Pascaline from Congo, have also died in recent days of the disease.
Pajares told the Spanish news agency EFE last week: “I would like to return [to Spain] because we have had very bad experiences here,” adding, “We want to travel to Spain so that they treat us like people, as is God’s will.”
He was transported back to Spain on a military Airbus 310 on Thursday last week, together with a colleague and Spanish nun, Juliana Bohi, who showed no symptoms of Ebola. A specialized medical team awaited his arrival and transferred him to a special isolated unit in the hospital.
According to Spain's drug safety agency, the "exceptional importation" of the experimental drug ZMapp was approved under a law allowing "the use of non-authorized medications in cases where a patent's life is in danger and they can't be treated satisfactorily with an authorized medication."
The use of ZMapp has sparked a controversy, where experts call for it to be made available to the African nations currently suffering Ebola outbreaks. However, the treatment, made by a private US company Mapp Pharmaceuticals, is reportedly still in a very early phase of development and has only, up until now, been tested on monkeys.
The video above shows the arrival of Pajares and Bohi in Madrid on August 7, 2014.
Spanish language source:
El Mundo
More about Miguel Pajares, Ebola, zmapp, Madrid, Liberia
More news from
Latest News
Top News